| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,94% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 0,61% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,30% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 0,13% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 0,79% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,21% | · | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 36,77% | 55,54% | 43,58% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | -19,34% | 7,52% | -32,65% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | -18,42% | 10,98% | -29,16% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | -13,81% | 9,46% | -18,28% | · |
